HANSAmed
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2830 Argentia Rd Units 5-9, Mississauga,...Phone Number
(231) 995-7603Website
www.hansamed.netRevenue
$5.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About HANSAmed
HANSAmed Limited, established in 1996, specializes in providing innovative dental solutions including regenerative biomaterials, anesthetics, and emergency preparedness products to dental professionals in Canada. The company is committed to quality and patient-centered care through exclusive product partnerships and industry-leading education. Their product range includes bone grafts, biologics, surgical essentials, and infection control solutions. HANSAmed also offers training and resources to support dental practices in delivering effective care.Explore more
HANSAmed Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is HANSAmed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
HANSAmed, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on HANSAmed recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at HANSAmed
Click to see if HANSAmed had a recent Job posting/layoffs
Check out if HANSAmed is spiking on competitors!
Funding: Get notified immidiatlly once HANSAmed has new funding data
Check if HANSAmed has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when HANSAmed launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to HANSAmed
Compare insights from companies similar to HANSAmed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
HANSAmed is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
HANSAmed is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about HANSAmed.
HANSAmed Tech Stack
A closer look at the technologies used by HANSAmed
HANSAmed News & Media
Antibe Therapeutics Announces Strategic Sale of Citagenix Subsidiary
TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, is pleased to announce the signing of a binding agreement to sell its Citagenix Inc. subsidiary to HANSAmed Limited (“HANSAmed”), a leading Canadian full-service distributor of pharmaceuticals and medical devices to dental professionals. “We are pleased with this result on several frontHealth Canada provides COVID-19 Interim Order approval for Bactiguard’s TempSensor catheter
Health Canada has approved Bactiguard’s urinary catheter with temperature sensor for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard’s catheters can reduce the risk of secondary infections for critically ill patients. “Many critically ill COVID-19 patients require a urinary catheter with integrated temperature monitoring. The ICU treatment period can be 14 days or more, which means patients will require an indwelling urinary catheter for a long peHealth Canada provides COVID-19 Interim Order approval for Bactiguard’s endotracheal tubes
Health Canada has approved Bactiguard’s endotracheal tubes for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard’s endotracheal tubes can reduce the risk of secondary infections for critically ill patients. “Many critically ill COVID-19 patients require intubation with an endotracheal tube (ETT) and mechanical ventilation. The ICU treatment period can be 14 days or more, which means patients will require ETTs for a long period of time. Each day of
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding HANSAmed
Sign Up For FreeTo access detailed company insights
HANSAmed Limited, established in 1996, specializes in providing innovative dental solutions including regenerative biomaterials, anesthetics, and emergency preparedness products to dental professionals in Canada. The company is committed to quality and patient-centered care through exclusive product partnerships and industry-leading education. Thei... Read More
